A pilot study identifying a potential plasma biomarker for determining EGFR mutations in exons 19 or 21 in lung cancer patients

The most common type of lung cancer is non-small cell lung cancer (NSCLC), which is frequently characterized by a mutation in the epidermal growth factor receptor (EGFR). Determining the presence of an EGFR mutation in lung cancer is important, as it determines the type of treatment that a patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Pamungkas, Aryo D., Medriano, Carl A., Sim, Eunjung, Lee, Sungyong, Park, Youngja H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436150/
https://www.ncbi.nlm.nih.gov/pubmed/28487968
http://dx.doi.org/10.3892/mmr.2017.6530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436150/
https://www.ncbi.nlm.nih.gov/pubmed/28487968
http://dx.doi.org/10.3892/mmr.2017.6530

Ejemplares similares